Our mission is to ensure the generation of accurate and precise findings.

GET UPDATE

Please enter subscribe form shortcode

2026.04.24.

What Can We Bring Out of Cyclodextrin Polymers at CarboHyde?

CarboHyde announces a research collaboration that has yielded a new publication. The team — including Salvo Sortino, Szabolcs Béni, and Milo Malanga — developed a photoresponsive β-cyclodextrin branched polymer. When exposed to visible blue light, the polymer generates nitric oxide. The researchers tested doxorubicin (DOX) in combination with the polymer, showing that light irradiation significantly […]

2026.04.22.

Check Out How CarboHyde Cyclodextrin Polymers Worked in Delivery!

Glioblastoma (GB) is the most common and aggressive malignant brain tumor, with a median survival of only 12–15 months. Emerging therapeutic approaches target the MAPK/ERK signalling pathway using MEK inhibitors such as trametinib and selumetinib. However, clinical progress faces obstacles including inadequate blood-brain barrier penetration and dose-limiting toxicity concerns. Researchers Noemi Bognanni, Graziella Vecchio, and […]